healthy subject
Conditions
Interventions
Bilberry extract 120mg/day, Lutein 6mg/day, 12weeks
Placebo, 12weeks
Sponsors
Omnica Co.,Ltd
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1, Healthy Japanese male and female 2, Aged=>20 years, <60 years 3, BMI =>25kg/m2 4, Subjects who feel eyestrain 5, Subjects who routinely carries out personal computer (PC) work or driving a car 6, Subjects who have not undergone LASIK. 7, Visual acuity with the naked eyes is 0.1 or more 8, Subjects who do not conscious of presbyopia 9, Subjects who can stop eye drops during the test period
Exclusion criteria
Exclusion criteria: 1, Subjects who have previous medical history of serious diseases (e.g., cancer, cardiac arrest, cardiac infarct). 2, Subjects who have previous medical history and/or current medical history of serious diseases(e.g., arrhythmia, liver disorder, renal disorder, cerebrovascular disorder, rheumatism, diabetes, dyslipidemia, hypertension, other chronic diseases) 3, Subjects who have undergone gastrointestinal tract surgery; except appendectomy. 4, Subjects who take medicines. 5, Subjects who have an eye disease. 6, Subjects who are allergic to medicines or the test material of this trial. 7, Subjects who are or are possibly pregnant, or are lactating. 8, Subjects who participate in other clinical trials in the past 3 months. 9, Subjects who work time is irregular. 10, Smoker 11, Subjects who have been determined ineligible by principal investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Near-reflex: intake 0,12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Contrast sensitivity: intake 0, 12 weeks MPOD: intake 0, 12 weeks Blood lutein concentration: intake 0, 12 weeks Subjective symptoms: intake 0,12 weeks Safety(blood test, urinary test, history taking):intake 0, 12 weeks | — |
Countries
Japan
Contacts
Public ContactMarie Kosehira
Omnica Co.,Ltd Research and development Dept.
Outcome results
None listed